Amniotic fluid pregnancy-specific beta 1-glycoprotein (SP1) in fetal developmental disorders.
Concentration of pregnancy-specific beta 1-glycoprotein (SP1) was studied in second and third trimester amniotic fluid from pregnancies with various fetal developmental disorders. The material consisted of 26 cases with chromosomal disorders and 19 cases with non-chromosomal fetal malformations. The SP1 concentration was elevated in two cases of Meckel's syndrome (mean +2.7-4.0 S.D.) as well as in one case of fetal triploidy (mean +22 S.D.), while it was normal in all other 14 different fetal disorders.
D000015:Abnormalities, Multiple / Q000175:diagnosis; D000649:Amniocentesis; D000653:Amniotic Fluid / Q000378:metabolism*; D002869:Chromosome Aberrations / Q000175:diagnosis* / Q000378:metabolism; D025063:Chromosome Disorders; D000013:Congenital Abnormalities / Q000175:diagnosis* / Q000378:metabolism; D005260:Female; D006801:Humans; D007621:Karyotyping; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000378:metabolism*; D011268:Pregnancy-Specific beta 1-Glycoproteins / Q000378:metabolism*
D011257:Pregnancy Proteins; D011268:Pregnancy-Specific beta 1-Glycoproteins